Σύγκριση μεθόδων

	Cochrane RoB 2.0	GRADE Evidence Profiling
Πεδίο	Μεθοδολογία Έρευνας	Μεθοδολογία Έρευνας
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2019	2008
Δημιουργός	Jonathan Sterne, Julian Higgins (Cochrane Collaboration)	Guyatt et al. (GRADE Working Group)
Τύπος	Clinician-rated / Research team assessment	Research team / Guideline panel assessment
Θεμελιώδης πηγή	Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898.	Guyatt, G., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008). GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924–926.
Εναλλακτικές ονομασίες	RoB 2.0, RoB 2	GRADE, GRADE approach
Συναφείς	4	4
Σύνοψη	RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias.	GRADE (Grading of Recommendations Assessment, Development and Evaluation) is a systematic, transparent framework for assessing the certainty of evidence and determining the strength of clinical recommendations in healthcare. Published in 2008 by Guyatt et al., GRADE has become the international standard for guideline development, used by the World Health Organization, Cochrane, and most major clinical guideline organizations worldwide.